# Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke

> **NCT01790997** · PHASE3 · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 126 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** DLBS1033
- **DRUG:** Aspirin
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01790997
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2014-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01790997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01790997, "Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01790997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*